The Food and Drug Administration has granted marketing approval for a tablet from Salix Pharmaceuticals for use in cleansing of the colon as a preparation for colonoscopy.

The table is called OsmoPrep. It was approved for use by adults age 18 and older.

“The approval of OsmoPrep is an important step forward in our effort to provide a product that makes bowel preparation for colonoscopy as effective, tolerable, easy and convenient as possible for patients,” said Bill Forbes, vice president of research and development and chief development officer at Salix. “This unique tablet formulation has been demonstrated to improve patient compliance and satisfaction.”